- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/025 - Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Patent holdings for IPC class C07K 14/025
Total number of patents in this class: 405
10-year publication summary
|
32
|
26
|
22
|
44
|
10
|
40
|
21
|
18
|
16
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sinocelltech Ltd. | 80 |
27 |
| Xiamen University | 534 |
20 |
| Xiamen Innovax Biotech Co., Ltd. | 89 |
18 |
| Inovio Pharmaceuticals, Inc. | 317 |
14 |
| The Trustees of the University of Pennsylvania | 4314 |
13 |
| Janssen Vaccines & Prevention B.V. | 295 |
12 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2842 |
10 |
| The Johns Hopkins University | 5652 |
8 |
| Beijing Health Guard Biotechnology, Inc. | 11 |
7 |
| Institut Pasteur | 786 |
6 |
| Inventprise, Inc. | 37 |
6 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 109 |
5 |
| Aura Biosciences, Inc. | 25 |
4 |
| Baylor College of Medicine | 943 |
4 |
| Baylor Research Institute | 237 |
4 |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 28 |
4 |
| The Council of the Queensland Institute of Medical Research | 156 |
4 |
| Deutsches Krebsforschungszentrum | 418 |
4 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 355 |
4 |
| Genticel | 9 |
4 |
| Other owners | 227 |